IL144012A - Method for the preparation of aryl ethers - Google Patents

Method for the preparation of aryl ethers

Info

Publication number
IL144012A
IL144012A IL14401299A IL14401299A IL144012A IL 144012 A IL144012 A IL 144012A IL 14401299 A IL14401299 A IL 14401299A IL 14401299 A IL14401299 A IL 14401299A IL 144012 A IL144012 A IL 144012A
Authority
IL
Israel
Prior art keywords
preparation
aryl ethers
ethers
aryl
epoxide
Prior art date
Application number
IL14401299A
Other languages
English (en)
Other versions
IL144012A0 (en
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of IL144012A0 publication Critical patent/IL144012A0/xx
Publication of IL144012A publication Critical patent/IL144012A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Compounds (AREA)
IL14401299A 1998-12-29 1999-12-23 Method for the preparation of aryl ethers IL144012A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11409298P 1998-12-29 1998-12-29
PCT/US1999/030748 WO2000039072A1 (en) 1998-12-29 1999-12-23 Method for the preparation of aryl ethers

Publications (2)

Publication Number Publication Date
IL144012A0 IL144012A0 (en) 2002-04-21
IL144012A true IL144012A (en) 2005-11-20

Family

ID=22353332

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14401299A IL144012A (en) 1998-12-29 1999-12-23 Method for the preparation of aryl ethers
IL16184099A IL161840A0 (en) 1998-12-29 1999-12-23 Method for the preparation of aryl ethers

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL16184099A IL161840A0 (en) 1998-12-29 1999-12-23 Method for the preparation of aryl ethers

Country Status (24)

Country Link
US (1) US6376711B1 (zh)
EP (2) EP1308443B1 (zh)
JP (1) JP2002533430A (zh)
KR (2) KR100616029B1 (zh)
CN (3) CN100340552C (zh)
AT (2) ATE260238T1 (zh)
AU (1) AU764492B2 (zh)
BR (1) BR9916615A (zh)
CA (1) CA2349619A1 (zh)
CO (1) CO5140125A1 (zh)
DE (2) DE69940833D1 (zh)
DK (1) DK1140788T3 (zh)
ES (1) ES2214060T3 (zh)
HK (3) HK1041688B (zh)
HU (1) HUP0202144A3 (zh)
IL (2) IL144012A (zh)
NZ (1) NZ511452A (zh)
PE (1) PE20001366A1 (zh)
PT (1) PT1140788E (zh)
SI (1) SI1140788T1 (zh)
TR (1) TR200101885T2 (zh)
TW (1) TWI238155B (zh)
WO (1) WO2000039072A1 (zh)
ZA (1) ZA200103532B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796069B3 (fr) * 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
AR030284A1 (es) * 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
CN1922124A (zh) * 2004-02-20 2007-02-28 法玛西雅厄普约翰公司 制备芳基醚的方法
WO2005082869A1 (en) * 2004-02-20 2005-09-09 Pharmacia & Upjohn Company Llc Method for the preparation of aryl ethers
WO2005095435A1 (ja) * 2004-03-31 2005-10-13 Kuraray Co., Ltd. プレグナン誘導体の製造方法
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
PT2076508E (pt) 2006-10-18 2011-03-07 Pfizer Prod Inc Compostos de ureia de éter biarílico
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
CN103804316A (zh) * 2012-11-13 2014-05-21 天津药物研究院 一种(2RS,3RS)-6-[a-(2-乙氧基苯氧基)苄基]吗啉-3-酮(Ⅰ)的制备方法
CN104557936A (zh) * 2015-01-15 2015-04-29 河南科技学院 一种新型手性非环嘌呤核苷类似物的合成方法
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785185A (en) * 1952-08-07 1957-03-12 Union Carbide & Carbon Corp Process for making oxirane compounds from olefins and aldehyde monoperacylates
GB1053972A (zh) * 1962-08-30 1967-01-04
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane

Also Published As

Publication number Publication date
KR20010099999A (ko) 2001-11-09
JP2002533430A (ja) 2002-10-08
ES2214060T3 (es) 2004-09-01
CN1636988A (zh) 2005-07-13
AU2381900A (en) 2000-07-31
ZA200103532B (en) 2002-08-02
CN1308332C (zh) 2007-04-04
ATE430144T1 (de) 2009-05-15
KR20060090310A (ko) 2006-08-10
CO5140125A1 (es) 2002-03-22
CN1249038C (zh) 2006-04-05
AU764492B2 (en) 2003-08-21
BR9916615A (pt) 2001-10-23
CN1332719A (zh) 2002-01-23
HUP0202144A3 (en) 2003-10-28
HK1078572A1 (en) 2006-03-17
CA2349619A1 (en) 2000-07-06
IL144012A0 (en) 2002-04-21
EP1308443A3 (en) 2003-10-01
DE69940833D1 (de) 2009-06-10
NZ511452A (en) 2002-11-26
HK1066004A1 (en) 2005-03-11
DE69915110D1 (de) 2004-04-01
TWI238155B (en) 2005-08-21
PE20001366A1 (es) 2000-11-19
KR100616029B1 (ko) 2006-08-28
ATE260238T1 (de) 2004-03-15
SI1140788T1 (en) 2004-08-31
US6376711B1 (en) 2002-04-23
IL161840A0 (en) 2005-11-20
CN100340552C (zh) 2007-10-03
WO2000039072A1 (en) 2000-07-06
HK1041688A1 (en) 2002-07-19
PT1140788E (pt) 2004-07-30
KR100616386B1 (ko) 2006-08-28
EP1140788B1 (en) 2004-02-25
EP1308443B1 (en) 2009-04-29
EP1140788A1 (en) 2001-10-10
HK1041688B (zh) 2007-12-07
CN1532194A (zh) 2004-09-29
HUP0202144A2 (hu) 2002-11-28
DE69915110T2 (de) 2004-08-26
TR200101885T2 (tr) 2002-01-21
DK1140788T3 (da) 2004-06-07
EP1308443A2 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
HK1078572A1 (en) Method for the preparation of aryl ethers
EP0945404A3 (de) Perameisensäure und Peressigsäure enthaltendes wässriges Desinfektionsmittel, Verfahren zu dessen Herstellung und dessen Verwendung
NO902954D0 (no) Fremgangsmaate for fremstilling av substituerte kinazolinoner som angitensin ii-antagonister.
GR3004139T3 (zh)
CY1107635T1 (el) Μεθοδος για την παρασκευη σιταλοπραμης
IL154014A0 (en) Process for the preparation of 2-aminoethylpyridines
IT1317031B1 (it) Procedimento migliorato per la preparazione di (e,z)3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
EP0850646A4 (en) LIPOSOMAL PREPARATIONS OF INDOLOCARBAZOLE DERIVATIVES
HU0201673D0 (zh)
FI910366A0 (fi) Menetelmä deoksimulundokandiinin valmistamiseksi
GB9811050D0 (en) Pyrazoles
GR1001203B (el) Μεθοδος παρασκευης της ενωσεως 24r-σκυμνολη.
AU5106100A (en) Antifucoidan antibody
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
AU7988387A (en) Diphenyl ether herbicides
JPS6471868A (en) Diphenyl ether herbicde
EP0502488A3 (en) Phosphorus-containing azetidin-2-one derivatives
EP1247880A3 (de) Verfahren zur Herstellung von Glycinderivaten und deren Verwendung
AU2001281992A1 (en) 2,2-disubstituted 1,3-dioxolanes as antitussive agents
AU3226389A (en) 7-(imidazol-1-yl)-1,4-dihydro-4-oxo-6,8-difluoro-1-cyclo- propylquinoline-3-carboxylic acid derivatives their preparation and their application as drugs

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees